Scintimun-H-C-PSUSA-00000385-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025

Human medicines European public assessment report (EPAR): Bevespi Aerosphere, glycopyrronium,formoterol fumarate dihydrate, Date of authorisation: 18/12/2018, Revision: 8, Status: Authorised

List of substances and products subject to worksharing for signal management

Pediatric Cluster Terms of Reference

Translating innovation into access for ATMPs: third EU-Innovation network multi-stakeholder meeting, Online, Rome, Italy, Broadcast, from 15 November 2024, 09:00 (CET) to 15 November 2024, 17:00 (CET)

Orphan designation: Eplontersen Treatment of transthyretin-mediated amyloidosis, 13/10/2023 Withdrawn

Briviact-H-C-PSUSA-00010447-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

EU NTC ten year anniversary event, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 30 May 2024, 09:00 (CEST) to 30 May 2024, 16:30 (CEST)

Report - EU NTC ten year anniversary event